The period circadian clock 2 gene responds to glucocorticoids and regulates osteogenic capacity.

Abe, Takahiro; Sato, Tomoya; Yoda, Tetsuya; Hoshi, Kazuto.

Afiliação

Abe T; Oral and Maxillofacial Surgery, Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Sato T; Department of Plastic and Reconstructive Surgery, Saitama Medical University, Saitama, Japan.
Yoda T; Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Hoshi K; Oral and Maxillofacial Surgery, Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Regen Ther ; 11: 199-206, 2019 Dec.

Article em En | MEDLINE | ID: mdl-31489343

Palavras-chave

ACTH, adrenocorticotropic hormone; ASPS, advanced sleep phase syndrome; BMSCs, bone marrow stem cells; BV/TV, bone volume/tissue volume; CRH, corticotropin-releasing hormone; Circadian rhythm; ES/BS, Eroded surface/ Bone surface; G.P.Th, growth plate thickness; Glucocorticoids; HPA-axis, hypothalamic-pituitary-adrenal-axis; MS/OS, Mineralizing surface/Osteoid surface; OS/BS, Osteoid surface/ Bone surface; OV/BV, Osteoid volume/ Bone volume; OV/TV, Osteoid volume/Tissue volume; Period circadian clock 2 gene; Second messenger; Tb.Th, Trabecular thickness

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article